PMC:3359311 / 0-383 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T378 0-21 NNP denotes Inflammasome-Mediated
T379 22-27 NNP denotes IL-1β
T380 28-38 NN denotes Production
T381 39-41 IN denotes in
T382 42-48 NNP denotes Humans
T383 49-53 IN denotes with
T384 54-60 NNP denotes Cystic
T385 61-69 NNP denotes Fibrosis
T386 117-127 NNP denotes Background
T387 128-140 NNP denotes Inflammation
T388 141-144 CC denotes and
T389 145-154 NN denotes infection
T390 155-158 VBP denotes are
T391 159-164 JJ denotes major
T392 165-177 NNS denotes determinants
T393 178-180 IN denotes of
T394 181-188 NN denotes disease
T395 189-197 NN denotes severity
T396 198-201 CC denotes and
T397 202-214 RB denotes consequently
T398 214-215 , denotes ,
T399 216-219 DT denotes the
T400 220-227 NN denotes quality
T401 228-230 IN denotes of
T402 231-235 NN denotes life
T403 236-239 CC denotes and
T404 240-247 NN denotes outcome
T405 248-251 IN denotes for
T406 252-260 NNS denotes patients
T407 261-265 IN denotes with
T408 266-272 JJ denotes cystic
T409 273-281 NN denotes fibrosis
T410 282-283 -LRB- denotes (
T411 283-285 NNP denotes CF
T412 285-286 -RRB- denotes )
T413 286-287 . denotes .
T414 288-301 NN denotes Interleukin-1
T415 302-306 NN denotes beta
T416 307-308 -LRB- denotes (
T417 308-313 NN denotes IL-1β
T418 313-314 -RRB- denotes )
T419 315-317 VBZ denotes is
T420 318-319 DT denotes a
T421 320-323 JJ denotes key
T422 324-336 JJ denotes inflammatory
T423 337-345 NN denotes mediator
T424 345-346 . denotes .
T425 347-356 NNP denotes Secretion
T426 357-359 IN denotes of
T427 360-372 RB denotes biologically
T428 373-379 JJ denotes active
R316 T378 T380 compound Inflammasome-Mediated,Production
R317 T379 T380 compound IL-1β,Production
R318 T380 T390 nsubj Production,are
R319 T381 T380 prep in,Production
R320 T382 T381 pobj Humans,in
R321 T383 T380 prep with,Production
R322 T384 T387 amod Cystic,Inflammation
R323 T385 T387 compound Fibrosis,Inflammation
R324 T386 T387 compound Background,Inflammation
R325 T387 T383 pobj Inflammation,with
R326 T388 T387 cc and,Inflammation
R327 T389 T387 conj infection,Inflammation
R328 T390 T390 ROOT are,are
R329 T391 T392 amod major,determinants
R330 T392 T390 attr determinants,are
R331 T393 T392 prep of,determinants
R332 T394 T395 compound disease,severity
R333 T395 T393 pobj severity,of
R334 T396 T390 cc and,are
R335 T397 T400 advmod consequently,quality
R336 T398 T400 punct ",",quality
R337 T399 T400 det the,quality
R338 T400 T390 conj quality,are
R339 T401 T400 prep of,quality
R340 T402 T401 pobj life,of
R341 T403 T402 cc and,life
R342 T404 T400 conj outcome,quality
R343 T405 T400 prep for,quality
R344 T406 T405 pobj patients,for
R345 T407 T406 prep with,patients
R346 T408 T409 compound cystic,fibrosis
R347 T409 T407 pobj fibrosis,with
R348 T410 T411 punct (,CF
R349 T411 T409 appos CF,fibrosis
R350 T412 T400 punct ),quality
R351 T413 T390 punct .,are
R352 T414 T415 compound Interleukin-1,beta
R353 T415 T419 nsubj beta,is
R354 T416 T417 punct (,IL-1β
R355 T417 T415 appos IL-1β,beta
R356 T418 T417 punct ),IL-1β
R357 T419 T419 ROOT is,is
R358 T420 T423 det a,mediator
R359 T421 T423 amod key,mediator
R360 T422 T423 amod inflammatory,mediator
R361 T423 T419 attr mediator,is
R362 T424 T419 punct .,is
R364 T426 T425 prep of,Secretion
R365 T427 T428 advmod biologically,active